102 related articles for article (PubMed ID: 11936816)
1. Projecting SEER cancer survival rates to the US: an ecological regression approach.
Mariotto A; Capocaccia R; Verdecchia A; Micheli A; Feuer EJ; Pickle L; Clegg LX
Cancer Causes Control; 2002 Mar; 13(2):101-11. PubMed ID: 11936816
[TBL] [Abstract][Full Text] [Related]
2. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
Feuer EJ; Rabin BA; Zou Z; Wang Z; Xiong X; Ellis JL; Steiner JF; Cynkin L; Nekhlyudov L; Bayliss E; Hankey BF
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):265-74. PubMed ID: 25417240
[TBL] [Abstract][Full Text] [Related]
3. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
Brenner H; Jansen L
J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
[TBL] [Abstract][Full Text] [Related]
4. Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data.
Kato I; Severson RK; Schwartz AG
Cancer; 2001 Oct; 92(8):2211-9. PubMed ID: 11596040
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
6. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
7. The impact of state-specific life tables on relative survival.
Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235
[TBL] [Abstract][Full Text] [Related]
8. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
9. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
[TBL] [Abstract][Full Text] [Related]
10. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
11. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
12. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data.
Liu Z; Zhang Y; Franzin L; Cormier JN; Chan W; Xu H; Du XL
Int J Oncol; 2015 Apr; 46(4):1819-26. PubMed ID: 25672365
[TBL] [Abstract][Full Text] [Related]
13. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
14. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas.
Lin SS; Clarke CA; Prehn AW; Glaser SL; West DW; O'Malley CD
Cancer; 2002 Feb; 94(4):1175-82. PubMed ID: 11920489
[TBL] [Abstract][Full Text] [Related]
15. Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC.
Rabin BA; Ellis JL; Steiner JF; Nekhlyudov L; Feuer EJ; Hankey BF; Cynkin L; Bayliss E
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):275-81. PubMed ID: 25417241
[TBL] [Abstract][Full Text] [Related]
16. Survival rates for four forms of cancer in the United States and Ontario.
Keller DM; Peterson EA; Silberman G
Am J Public Health; 1997 Jul; 87(7):1164-7. PubMed ID: 9240107
[TBL] [Abstract][Full Text] [Related]
17. Projection of incidence rates to a larger population using ecologic variables.
Frey CM; Feuer EJ; Timmel MJ
Stat Med; 1994 Sep; 13(17):1755-70. PubMed ID: 7997709
[TBL] [Abstract][Full Text] [Related]
18. Cancer survival in five continents: a worldwide population-based study (CONCORD).
Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
[TBL] [Abstract][Full Text] [Related]
19. Mortality rates by stage-at-diagnosis.
Clinton K
Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787
[TBL] [Abstract][Full Text] [Related]
20. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
